• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机硝酸盐:新制剂及其临床优势。

Organic nitrates: new formulations and their clinical advantages.

作者信息

Parker J A

机构信息

Kingston General Hospital, Ontario, Canada.

出版信息

Am J Cardiol. 1996 May 30;77(13):38C-40C. doi: 10.1016/s0002-9149(96)00187-7.

DOI:10.1016/s0002-9149(96)00187-7
PMID:8638525
Abstract

The organic nitrates have been used for more than a century in the management of patients with myocardial ischemia. The most commonly used agents at this time include nitroglycerin, isosorbide dinitrate, and isosorbide-5-mononitrate. These agents all exert their therapeutic effects through biodegradation to nitric oxide, which stimulates guanylate cyclase in vascular smooth muscle cells with the production of cyclic guanosine monophosphate. The latter induces vasodilation by reducing the availability of ionized calcium to the contractile proteins. Tolerance to the organic nitrates occurs when the agents are administered in an attempt to provide therapeutic effects throughout 24 hours each day. There are probably several mechanisms responsible for nitrate tolerance, but there is no evidence at this time that concurrent medications will modify the development of tolerance. The only available method at this time is to give these agents intermittently to provide a period of washout. In so doing, it is possible to provide therapeutic nitrate effects for approximately 12 hours throughout each 24-hour period.

摘要

有机硝酸盐用于治疗心肌缺血患者已有一个多世纪。目前最常用的药物包括硝酸甘油、异山梨醇二硝酸酯和5-单硝酸异山梨酯。这些药物均通过生物降解产生一氧化氮发挥治疗作用,一氧化氮刺激血管平滑肌细胞中的鸟苷酸环化酶,生成环磷酸鸟苷。后者通过减少离子钙与收缩蛋白的结合来诱导血管舒张。当每天试图24小时持续给药以提供治疗效果时,会出现对有机硝酸盐的耐受性。硝酸盐耐受性可能有多种机制,但目前尚无证据表明同时使用其他药物会改变耐受性的发展。目前唯一可行的方法是间歇性给药,留出一段洗脱期。这样,每24小时内大约有12小时可提供治疗性硝酸盐效应。

相似文献

1
Organic nitrates: new formulations and their clinical advantages.有机硝酸盐:新制剂及其临床优势。
Am J Cardiol. 1996 May 30;77(13):38C-40C. doi: 10.1016/s0002-9149(96)00187-7.
2
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.硝酸甘油和有机硝酸盐。给药方法的选择。
Drugs. 1987 Sep;34(3):391-403. doi: 10.2165/00003495-198734030-00005.
3
Nitrate tolerance--can it be prevented?硝酸酯类药物耐受性——能否预防?
Eur Heart J. 1991 May;12 Suppl A:13-5.
4
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.有机硝酸盐疗法、硝酸盐耐受性与硝酸盐诱导的内皮功能障碍:着重于氧化还原生物学与氧化应激
Antioxid Redox Signal. 2015 Oct 10;23(11):899-942. doi: 10.1089/ars.2015.6376. Epub 2015 Sep 24.
5
[Recent findings on nitrates: their action, bioactivation and development of tolerance].[硝酸盐的最新研究成果:其作用、生物活化及耐受性的发展]
Dtsch Med Wochenschr. 2008 Oct;133(44):2277-82. doi: 10.1055/s-0028-1091272. Epub 2008 Oct 22.
6
Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.有机硝酸盐的非血流动力学效应及戊四硝酯的独特特性。
Am J Cardiovasc Drugs. 2009;9(1):7-15. doi: 10.1007/BF03256591.
7
Nitrates.硝酸盐
AACN Clin Issues Crit Care Nurs. 1992 May;3(2):409-22. doi: 10.4037/15597768-1992-2013.
8
Efficacy of different forms of nitrates in angina pectoris.不同形式硝酸盐类药物治疗心绞痛的疗效
Acta Med Scand Suppl. 1985;694:153-65. doi: 10.1111/j.0954-6820.1985.tb08811.x.
9
Mechanisms of action of nitrates.硝酸盐的作用机制。
Cardiovasc Drugs Ther. 1994 Oct;8(5):701-17. doi: 10.1007/BF00877117.
10
Beneficial actions of nitrates in cardiovascular disease.硝酸盐在心血管疾病中的有益作用。
Am J Cardiol. 1996 May 30;77(13):31C-7C. doi: 10.1016/s0002-9149(96)00186-5.

引用本文的文献

1
Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.硝酸盐类药物用于预防非心脏手术患者的心脏发病率和死亡率。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD010726. doi: 10.1002/14651858.CD010726.pub2.
2
Stimulators of soluble guanylyl cyclase: future clinical indications.可溶性鸟苷酸环化酶刺激剂:未来的临床应用指征
Ochsner J. 2013 Spring;13(1):147-56.
3
Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.可溶性鸟苷酸环化酶的刺激剂和激活剂:综述与潜在治疗适应症
Crit Care Res Pract. 2012;2012:290805. doi: 10.1155/2012/290805. Epub 2012 Feb 28.
4
Nitrates and nitrites in the treatment of ischemic cardiac disease.硝酸盐和亚硝酸盐在缺血性心脏病治疗中的应用。
Cardiol Rev. 2010 Jul-Aug;18(4):190-7. doi: 10.1097/CRD.0b013e3181c8e14a.
5
Headache-type adverse effects of NO donors: vasodilation and beyond.NO 供体的头痛样不良反应:血管扩张及其他。
Br J Pharmacol. 2010 May;160(1):20-35. doi: 10.1111/j.1476-5381.2010.00643.x. Epub 2010 Mar 19.